Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Aug 28, 2014; 20(32): 11210-11215
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11210
Published online Aug 28, 2014. doi: 10.3748/wjg.v20.i32.11210
Selection criteria in resectable pancreatic cancer: A biological and morphological approach
Domenico Tamburrino, Stefano Partelli, Stefano Crippa, Alberto Manzoni, Angela Maurizi, Massimo Falconi, Pancreatic Surgery Unit, Department of Surgery, Polytechnic University of Marche Region, 60126 Ancona-Torrette, Italy
Author contributions: Crippa S, Manzoni A and Maurizi A performed the review of the literature; Tamburrino D and Partelli S wrote the paper under the supervision of Falconi M.
Correspondence to: Massimo Falconi, MD, Pancreatic Surgery Unit, Department of Surgery, Polytechnic University of Marche Region, Via Conca 71, 60126 Ancona-Torrette, Italy. m.falconi@univpm.it
Telephone: +39-71-5965781 Fax: +39-71-5964429
Received: November 5, 2013
Revised: February 13, 2014
Accepted: April 15, 2014
Published online: August 28, 2014
Revised: February 13, 2014
Accepted: April 15, 2014
Published online: August 28, 2014
Core Tip
Core tip: The aim of this work was to improve identification of patients with pancreatic ductal adenocarcinoma, who will benefit from pancreatic resection. Duration of symptoms and level of carbohydrate antigen 19.9 in patients with resectable disease should be considered to avoid R1 resection and early relapse. Radiological assessment can help surgeons to distinguish resectable disease from borderline resectable disease and locally advanced pancreatic cancer.